Immunic Inc (IMUX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,272 | -120,407 | -63,933 | -42,709 | -20,808 |
| Depreciation Amortization | 32 | 33,047 | 58 | 41 | 21 |
| Accounts payable and accrued liabilities | 986 | 799 | 1,151 | 826 | -350 |
| Other Working Capital | 3,181 | 9,530 | 3,575 | -10 | -2,112 |
| Other Operating Activity | 1,560 | 11,887 | 9,109 | 5,408 | 2,568 |
| Operating Cash Flow | $-19,513 | $-65,144 | $-50,040 | $-36,444 | $-20,681 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,439 | -9,629 | N/A | N/A | N/A |
| PPE Investments | -104 | -112 | -113 | -40 | -12 |
| Investing Cash Flow | $5,335 | $-9,741 | $-113 | $-40 | $-12 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 51 | 95,760 | 39,719 | 39,589 | 29,643 |
| Other Financing Activity | 0 | 0 | 0 | 130 | 0 |
| Financing Cash Flow | $51 | $95,760 | $39,719 | $39,719 | $29,643 |
| Exchange Rate Effect | 143 | -993 | -3,658 | -2,020 | -103 |
| Beginning Cash Position | 106,745 | 86,863 | 86,863 | 86,863 | 86,863 |
| End Cash Position | 92,761 | 106,745 | 72,771 | 88,078 | 95,710 |
| Net Cash Flow | $-13,984 | $19,882 | $-14,092 | $1,215 | $8,847 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,513 | -65,144 | -50,040 | -36,444 | -20,681 |
| Capital Expenditure | -104 | -112 | -113 | -40 | -12 |
| Free Cash Flow | -19,617 | -65,256 | -50,153 | -36,484 | -20,693 |